Study of Intravenous Erenumab in Patients With Status Migrainosus

NCT04920331 · clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped No Participants Enrolled

Conditions

Interventions

Sponsor

Mayo Clinic